Real Life Treatment Regimen of Remicade (Infliximab) in Austria, Monitored Over 5 Years in Plaque Psoriasis Therapy
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2014
At a glance
- Drugs Infliximab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme; Schering-Plough
- 01 Sep 2011 Actual end date (June 2010) added as reported by ClinicalTrials.gov.
- 01 Sep 2011 Primary endpoint identified as therapy assessment as reported by ClinicalTrials.gov.
- 12 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.